Editorial: Introduction of the National Meningococcal C Vaccination Program
DOI:
https://doi.org/10.33321/cdi.2003-27-29Keywords:
meningococcal C conjugate vaccine, vaccination, vaccination programAbstract
In January 2003, the Commonwealth Government commenced the National Meningococcal C Vaccination Program. This program provides free meningococcal C conjugate vaccine over the next four years to all children and adolescents who turn one to 19 years of age in 2003, a target group of almost 6 million. The meningococcal C vaccine has also been added to the Australian Standard Vaccination Schedule at 12 months of age.
Downloads
References
Wyeth Australia Pty Ltd. MIMS Abbreviated Prescribing Information for Meningitec. MIMS Online. 2003. Available from: http://mims.hcn.net.au. Accessed on 1 April 2003.
Communicable Diseases Network Australia. National Notifiable Diseases Surveillance System - annual diseases data. Commonwealth Department of Health and Ageing. 2003. Available from: www.health.gov.au/pubhlth/cdi/nndss/nndss2.htm Accessed on 1 April 2003. [Access to Australia's National Notifable Diseases Surveillance System data has since been replaced by a dynamic data retrieval system available at: http://www9.health.gov.au/cda/source/cda-index.cfm]
Communicable Diseases Network Australia. Guidelines for the early clinical and public health management of meningococcal disease in Australia. Canberra: Commonwealth Department of Health and Aged Care; 2001.
Australian Technical Advisory Group on Immunisation. Recommendations on the use of meningococcal C conjugate vaccine in the Australian population. Canberra: Department of Health and Ageing; 2003 (in press).
Department of Health, England. Meningitis C vaccine. Department of Health, England. 2003. Available from: www.doh.gov.uk/meningitis-vaccine/index.htm. Accessed on 1 April 2003. [This page has been moved to www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/MeningitisC/MeningitisGeneralInformation/fs/en]
Miller E, Salisbury D and Ramsay M. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 2002;20:S58-S67.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2003 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
